Colgate-Palmolive Company $CL Shares Sold by Hussman Strategic Advisors Inc.

Hussman Strategic Advisors Inc. lowered its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 20.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 42,000 shares of the company’s stock after selling 10,500 shares during the period. Colgate-Palmolive comprises 0.7% of Hussman Strategic Advisors Inc.’s portfolio, making the stock its 19th largest holding. Hussman Strategic Advisors Inc.’s holdings in Colgate-Palmolive were worth $3,357,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in CL. Little House Capital LLC lifted its holdings in Colgate-Palmolive by 1.8% in the 3rd quarter. Little House Capital LLC now owns 9,386 shares of the company’s stock valued at $750,000 after purchasing an additional 169 shares in the last quarter. J. Safra Sarasin Holding AG raised its position in shares of Colgate-Palmolive by 0.8% in the third quarter. J. Safra Sarasin Holding AG now owns 739,508 shares of the company’s stock valued at $59,118,000 after buying an additional 6,209 shares during the last quarter. Phoenix Financial Ltd. lifted its stake in shares of Colgate-Palmolive by 35.4% during the third quarter. Phoenix Financial Ltd. now owns 5,546 shares of the company’s stock valued at $443,000 after buying an additional 1,449 shares during the period. KPP Advisory Services LLC boosted its position in Colgate-Palmolive by 16.9% during the third quarter. KPP Advisory Services LLC now owns 13,809 shares of the company’s stock worth $1,104,000 after acquiring an additional 1,993 shares during the last quarter. Finally, Bank of Jackson Hole Trust grew its stake in Colgate-Palmolive by 65.6% in the 3rd quarter. Bank of Jackson Hole Trust now owns 1,982 shares of the company’s stock worth $158,000 after acquiring an additional 785 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $85.86 on Wednesday. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.93 and a quick ratio of 0.60. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The company has a market capitalization of $69.21 billion, a price-to-earnings ratio of 24.05, a PEG ratio of 5.75 and a beta of 0.30. The business has a 50-day moving average of $80.32 and a 200-day moving average of $81.37.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The firm had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. During the same period in the previous year, the company posted $0.91 EPS. Colgate-Palmolive’s revenue for the quarter was up 1.9% on a year-over-year basis. On average, equities analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.26%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Barclays set a $83.00 price target on shares of Colgate-Palmolive in a research note on Friday, January 16th. Jefferies Financial Group set a $85.00 target price on Colgate-Palmolive in a report on Tuesday, December 16th. Morgan Stanley dropped their price target on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a research note on Monday, November 3rd. Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Thursday, December 11th. Finally, Evercore ISI dropped their target price on shares of Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating for the company in a research report on Monday, November 3rd. Eleven investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $89.44.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.